Buy-side analysts at pharma-focused funds

BD&L executives at pharma companies

Clinical researchers & developers

Technical due diligence for Mergers and Acquisitions, licensing and partnership

Pharmaceutical portfolio de-risking

Competitive analysis

Search for the assets to invest in

Investment portfolio de-risking

AI-augmented trial design - endpoints, sites, eligibility

Research on general red flags

Post-mortem analysis on failed projects for possible revival

Proprietary ML algorithms for information extraction & data harmonization

Comprehensively harmonized public data with targeted bridges of manually curated datasets

Advanced NLP system with a feedback loop from the annotation experts

Large preclinical data feed from CROs

Comprehensive and uniform data

- score the clinical trial that you are planning

- find out which clinical trial protocol features influence the probability of success the most in therapeutic area

- highlight important parts of the clinical trial protocol that affect probability of sucess

- optimize your clinical trial protocol to improve the probability of success

inClinico for the clinical trial design:

- find the pharma company and its pharmaceutical assets

- assess the risk of the companies development pipeline

- estimate the NPV more precisely

- compare the pharmaceutical asset with competitor programs

inClinico for the due diligence on pharmaceutical development pipeline: